Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity
This email address is used for sending the document.
